REVISED ABSTRACT

Background Omadacycline OMC is the first of a new class of tetracyclines the aminomethylcyclines and is being developed as a oncedaily oral and IV treatment for acute bacterial skin and skin structure infection ABSSSI and communityacquired bacterial pneumonia CABP The objective of the present study was to evaluate the bactericidal activity of OMC compared with other antibacterial

Embed this Presentation

Download Notice

Download Presentation The PPT/PDF document "REVISED ABSTRACT" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.